Compounds > threonine

threonine and Bone Cancer

threonine has been researched along with Bone Cancer in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Xu, X; Yu, H	1
Hawkins, CJ; Patatsos, K; Shekhar, TM	1
Guo, QL; Ha, J; Hu, R; Lu, N; Qi, Q; Rong, JJ; Song, XM; Tao, L; You, QD	1
Li, AG; Li, HH; Liu, X; Sheppard, HM	1
Barrientes, S; Cooke, C; Goodrich, DW	1

Other Studies

5 other study(ies) available for threonine and Bone Cancer

Article	Year
Ras-PI3K pathway promotes osteosarcoma progression via regulating VRK1-mediated H2A phosphorylation at threonine 120. Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1 Topics: Bone Neoplasms; Cell Line, Tumor; Histones; Humans; Intracellular Signaling Peptides and Proteins; Osteosarcoma; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; ras Proteins; Threonine; Transcription, Genetic; Up-Regulation	2019
Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma. Veterinary and comparative oncology, 2018, Volume: 16, Issue:4 Topics: Aniline Compounds; Animals; Antineoplastic Agents; Bone Neoplasms; Boron Compounds; Boronic Acids; Bortezomib; Carboplatin; Cell Line, Tumor; Dog Diseases; Dogs; Doxorubicin; Glycine; Humans; Oligopeptides; Osteosarcoma; Proteasome Inhibitors; Sulfonamides; Threonine	2018
Gambogic acid triggers DNA damage signaling that induces p53/p21(Waf1/CIP1) activation through the ATR-Chk1 pathway. Cancer letters, 2010, Oct-01, Volume: 296, Issue:1 Topics: Androstadienes; Antineoplastic Agents; Bone Neoplasms; Caffeine; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Down-Regulation; Doxorubicin; Hep G2 Cells; Humans; Osteosarcoma; Phosphorylation; Phosphothreonine; Signal Transduction; Threonine; Tumor Suppressor Protein p53; Wortmannin; Xanthones	2010
Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Molecular cell, 2004, Mar-26, Volume: 13, Issue:6 Topics: Alanine; Amino Acid Substitution; Antineoplastic Agents; Apigenin; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Damage; Drug Stability; Flavonoids; G1 Phase; Histone Acetyltransferases; Humans; Nuclear Proteins; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; TATA-Binding Protein Associated Factors; Threonine; Transcription Factor TFIID; Transfection; Tumor Suppressor Protein p53	2004
Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function. Oncogene, 2000, Jan-27, Volume: 19, Issue:4 Topics: Bone Neoplasms; Cell Cycle; Cell Line; Cyclin-Dependent Kinases; Genes, Retinoblastoma; Glutamic Acid; Humans; Kidney; Mutagenesis, Site-Directed; Osteosarcoma; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Recombinant Fusion Proteins; Retinoblastoma Protein; Serine; Structure-Activity Relationship; Threonine; Transfection; Tumor Cells, Cultured	2000